Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 12, Number 10—October 2006

Malaria Epidemics and Interventions, Kenya, Burundi, Southern Sudan, and Ethiopia, 1999–2004

Francesco Checchi*†Comments to Author , Jonathan Cox†, Suna Balkan‡, Abiy Tamrat§, Gerardo Priotto*, Kathryn P. Alberti*, Dejan Zurovac‡¶#, and Jean-Paul Guthmann*
Author affiliations: *Epicentre, Paris, France; †London School of Hygiene and Tropical Medicine, London, United Kingdom; ‡Médecins Sans Frontières, Paris, France; §Médecins Sans Frontières, Geneva, Switzerland; ¶Kenya Medical Research Institute/Wellcome Trust Research Laboratories, Nairobi, Kenya; #University of Oxford, Oxford, United Kingdom

Main Article

Table 2

Details of operational response to malaria epidemics by intervention site*

Factor Kisii/Gucha, Kenya Kayanza, Burundi Aweil East, southern Sudan Gutten, Ethiopia Damot Gale, Ethiopia
Delay of intervention (wks) 7 7 3 >12, probably 19 20
Inpatient care
Expansion in bed capacity From 310 to 510 beds From 65 to 125 beds From ≈80 to ≈120 beds From 2 to ≈100 beds From 12 to >100 beds
Treatment IM/IV quinine, IM artemether IM/IV quinine IM artemether IV quinine IV/IR quinine
Diagnosis Presumptive Blood slide RDT RDT RDT
Fixed outpatient care
Increase in capacity 2 additional OPDs Increased capacity in 5 OPDs, 2 additional OPDs Conversion of nutritional centers, 2 additional OPDs 1 additional OPD Supervision and drug supply to 5 OPDs
Treatment SP CQ+SP AS+SP Quinine (IR if vomited) SP, quinine
Diagnosis Presumptive Presumptive RDT RDT RDT
Mobile clinics
Number 3 6 14 5 Not available
Catchment population 302,000 Not available 144,000 44,000 73,000
Sites visited 45 10 43 5 14
Days per site per week (wks of operation) 0.2–0.3 (7) 1.2 (22) 1–2 (15) 2 (13) 0.2–0.5 (4)
Treatment SP, AS+SP (73.4% of cases) CQ+SP AS+SP, artemether for severe cases Quinine Quinine
Diagnosis Presumptive Presumptive Presumptive RDT RDT

*IM, intramuscular; IV, intravenous; IR, intrarectal; RDT, rapid diagnostic test; OPD, outpatient department; SP, sulfadoxine-pyrimethamine; CQ, chloroquine; AS, artesunate.

Main Article

Page created: November 10, 2011
Page updated: November 10, 2011
Page reviewed: November 10, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.